CTT Pharmaceutical Holdings Inc, (OTC: CTTH), a life sciences company with a portfolio of IP in novel drug delivery systems, announced yesterday that it has named Bob Allen as its new CFO and Marc Lakmaaker as strategic advisor.
Allen has acted as both CFO and CEO to large public corporations, including Ainsworth Lumber and the TimberWest Forest Corporation. He is an investor, entrepreneur and C-Suite executive with more than 20 years of experience in building, leading, and advising both public and private companies, including executing M&A and capital market transactions.
Lakmaaker is an executive with more than 20 years of capital markets, management and communications experience. He has knowledge of the cannabis industry, with a strong network of analysts, investors, influencers and industry participants. Lakmaaker is the founder of Clearview Capital Consult, a strategic and communications advisory focused on the cannabis, technology and industrial technology sectors. Prior to this, he was head of investor relations and director of Corporate Development at Aurora Cannabis. He will be working with management on the development and execution of corporate and capital markets strategies.
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees